Total Raised

$35.1M

Investors Count

11

Deal Terms

2

Funding, Valuation & Revenue

4 Fundings

EyeYon Medical has raised $35.1M over 4 rounds.

EyeYon Medical's latest funding round was a Series C for $25M on March 15, 2021.

EyeYon Medical's latest post-money valuation is from March 2021.

Sign up for a free demo to see EyeYon Medical's valuations in March 2021 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

3/15/2021

Series C

$25M

$XXM

0

FY undefined

13

3/21/2017

Series B

$XXM

$XXM

0

FY undefined

10

4/6/2015

Series A

$XXM

$XXM

0

FY undefined

10

Other Investors

$XXM

0

FY undefined

0

Date

3/15/2021

3/21/2017

4/6/2015

Round

Series C

Series B

Series A

Other Investors

Amount

$25M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

13

10

10

0

Start free trial
New call-to-action

EyeYon Medical Deal Terms

2 Deal Terms

EyeYon Medical's deal structure is available for 2 funding rounds, including their Series C from March 15, 2021.

Round

Series C

Series B

Funding Date

$XXM

$XXM

Pre-Money Valuation

$XXM

Post-Money Valuation

$XXM

Amount Raised

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

Board Voting

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series B

$XXM

$XXM

$XXM

$XXM

EyeYon Medical Investors

11 Investors

EyeYon Medical has 11 investors. Triventures invested in EyeYon Medical's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/6/2015

3/15/2021

3
Series A, Series B (2017), Series C (2021)

Venture Capital

Israel

4/6/2015

3/15/2021

3
Series A, Series B (2017), Series C (2021)

Venture Capital

Israel

3/21/2017

3/15/2021

2
Series B, Series C (2021)

Venture Capital

China

00/00/0000

00/00/0000

Quark Venture

Subscribe to see more

Venture Capital

Canada

00/00/0000

00/00/0000

GF Securities

Subscribe to see more

Asset/Investment Management

China

First funding

4/6/2015

4/6/2015

3/21/2017

00/00/0000

00/00/0000

Last Funding

3/15/2021

3/15/2021

3/15/2021

00/00/0000

00/00/0000

Investor

Quark Venture

GF Securities

Rounds

3
Series A, Series B (2017), Series C (2021)
3
Series A, Series B (2017), Series C (2021)
2
Series B, Series C (2021)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Venture Capital

Venture Capital

Venture Capital

Asset/Investment Management

Location

Israel

Israel

China

Canada

China

New call-to-action

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.